On 26 Sep, before market opened, China Animal (“CAL”) announced that it has entered into a conditional Subscription Agreement with two new investors, Themes and SEB Listed PE Fund for subscription of Subscription Shares and Warrants. If the conditions to the Subscription are satisfied, this would raise an aggregate amount of S$47.7m to be primarily used to partly fund the Possible Delisting Offer.
More than 3 months have passed (and pertaining to the delisting), CAL had updated investors that “the arranging of third-party financing for the Possible Delisting and other associated workstreams are now at an advanced stage and are ongoing as at the date of this announcement” I believe most investors have already given up on this as news / rumours on CAL’s potential delisting started as early as May 2011. On 18 Oct 2011, CAL announced that a potential delisting is one of their corporate evaluation considerations. On 22 May 2012, CAL formally announced that it is seeking a potential delisting with a cash exit offer of $0.300 / share, subject to several conditions herein
http://info.sgx.com/webcoranncatth.nsf/VwAttachments/Att_7B5E6766665AF36B48257A06004E4FB2/$file/Chinanimal_E_Ann.pdf?openelementPersonal takeaways to this string of developments:
1. After the 26 Sep announcement, CAL seems to be a step closer to delisting (but not confirmed) as it signifies
a) Company manages to secure some funding for the potential delisting exercise, subject to the conditions in the subscription agreement;
b) Management’s continuous efforts and determination to delist from Singapore;
2. There is a Long Stop Date 31 Mar 2013 where the Subscription Agreement will lapse if the conditions below are not fulfilled.
Company has to obtain
(i) the approval of its Shareholders in general meeting for the Possible Delisting and the Possible Delisting Offer; and
(ii) the Listing Approval.
CAL signed this agreement on 25 Sep 2012 and they provided the Long Stop Date to be half a year later on 31 Mar. It seems to me that they are reasonably confident that it can be done. If not, all their efforts (spanning more than a year or 1.5 years in my estimate) would go down the drain.
If my above guess is true, then CAL should announce they manage to secure funding latest in the next couple of months lest there is not enough time to convene a Shareholder meeting and seek the various authorities’ approval etc.
Do note that the above is my personal opinion on the matter and is highly speculative. It is not suitable to all readers as the risk profile of each person differs. If the subscription agreement lapses or if they drop their delisting proposal, CAL share price may plunge.
Readers who want to research more into CAL can email me at
crclk@yahoo.com.sg. I will send you some analyst reports and financial statements on CAL.
*This is an amended version which I sent out to my clients on 5 Jan 2013 where it was trading around $0.250.
Disclaimer
The information contained herein is the writer’s personal opinion and is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided herein do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or invest in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein are suitable for you. The writer will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials appended herein. The information and/or materials are provided “as is” without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.
Thanks in favor of sharing such a fastidious thinking,
What’s Taking place i’m new to this, I stumbled upon this I’ve discovered It absolutely useful and it has helped me out loads. I am hoping to give a contribution & help different users like its aided me. Good job.
отступление русской армии от смоленска в 1812 рассказ про калининград для 2 класса речные перевозки в сыктывкаре
масленица в челябинска доманова анна васильевна сергиев посад белые платья
белгород
Obtenez votre médicaments sans quitter votre domicile Zydus Collegno
Commandez votre médicaments en ligne au Québec
médicaments disponible en ligne sans ordonnance Genfar Acacías trouver des médicaments similaires
à un prix abordable
одежда из спортмастера в рязани забор
из профнастила цена северодвинск дом творчества на яблочкова
астрахань
программа русский роман на сегодня весь день
красноярск меню ривьера хабаровск аренда машины таганрог посуточно
médicaments sans ordonnance médicale Basi Dübendorf médicaments
vente libre pays
medicijnen bestellen in Vlaardingen – snel en gemakkelijk.
lek Capaci Achat de médicaments sur Internet :
astuces pour éviter les contrefaçons
Hello mates, its fantastic piece of writing on the topic of teachingand completely
defined, keep it up all the time.
compra de medicamentos en Italia galpharm Diemen descuentos
en medicamentos
азия ірі мемлекеттері, алып
мемлекеттер азия наступит завтра или нет кинопоиск, и в печали, и в радости скачать фильм ауа райының адам денсаулығына әсері,
климат адам ағзасына әсер ете ме эссе босану
кезеңдері слайд, босану презентация
ферма пшеницы create, сорт пшеницы барыс мейірімді жүрек жылы тілек эссе, мейірімді жүрек
эссе жер сілкінісі кезінде қауіпсіздік ережесі, жер сілкінісі кезінде
не істеу керек айкын армандастар скачать, дос-мукасан
армандастар скачать
ш айтматов ана – жер ана ответы, ш.айтматов ана жер ана сабақ жоспары идея недеяния, конфуцианство кун куатынын жерге отетин болиги,
жердің радиусы кестені құрайтын негізгі
компоненттер, мәліметтер қорының негізгі элементтері
заговор на работу чтобы ладилось на работе когда
стричь волосы в декабре по оракулу сонники во сне видела крысу
известные карты таро рейтинг самых ревнивых знаков зодиака зодиаков
тұрақты ток машиналарының
жұмыс істеу принципі, тұрақты ток машиналары презентация орташа айлық табыс 2022,
ең төменгі жалақы 2022 ө тұрманжанов қай жылы
қай жерде туған, ө.тұрманжанов шығармалары қысқы демалыс күндері, қысқы демалыс күндері
2022
олар пайғамбарымызды осылай сүйген кітап алматы, олар пайғамбарымызды осылай
көрген адам анатомиясы кітап, адам анатомиясы 3 том қан қандай ұлпаға жатады, оттекті тасымалдайтын қан жасушасы бесплатные курсы арабского языка онлайн, курсы арабского языка в мечети алматы
medicijnen online bestellen: Snelle levering gegarandeerd
Biofarma Ensenada medicamentos disponible en Quito